Beta Drugs Market Cap ($253.69M USD)
Beta Drugs Market Cap ($253.69M USD). As of Oct. 5, 2026, Beta Drugs (BETA) market capitalisation is ₹2283.19 Cr ($253.69M), with 1.14 Cr shares outstanding at a current price of ₹2004.00 on NSE, ranking 1138 out of 5368 companies by market cap in our screener. Beta Drugs operates in the Healthcare sector and is classified as a Small Cap stock. Examine BETA quarterly results for recent quarterly revenue, profit and EPS trends.
Market Cap History of Beta Drugs (Last 10 Years)
BETA market capitalisation from year-end NSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see Beta Drugs share price chart.
End of Year Market Cap History — Beta Drugs
BETA year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Compare with BETA DCF valuation to assess whether the stock is under or overvalued.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹2283.19 Cr
$253.69M USD
|
₹2004.00 | NSE | +29.37% |
| 2025 |
₹1764.91 Cr
$196.10M USD
|
₹1549.10 | NSE | - |